StonvexLoading…
StonvexStonvexStonvexCore line items from CMCSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $31.46B | $123.71B | $91.40B | $60.20B |
Operating Income | $4.13B | $20.67B | $17.18B | $11.65B |
Net Income | $2.17B | $20.00B | $17.83B | $14.50B |
EPS (Diluted) | $0.60 | $5.39 | $4.78 | $3.86 |
Total Assets | $260.00B | $272.63B | $273.00B | $273.85B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.47B | $9.48B | $9.32B | $9.69B |
Free Cash Flow OCF − CapEx | $4.54B | $21.89B | $16.80B | $11.18B |
Shares Outstanding | 3.62B | 3.71B | 3.73B | 3.76B |